Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo

Journal of Lipid Research

Volumn 39, Issue 9, 1998, Pages 1740-1743

  Roselaar, Simon E ^a   Daugherty, Alan ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Immunity; Macrophages

Indexed keywords

APOLIPOPROTEIN E;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HOST RESISTANCE; IMMUNOREACTIVITY; INFECTION RESISTANCE; LIPOPROTEIN DEFICIENCY; LISTERIA MONOCYTOGENES; LIVER; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

ANIMALS; APOLIPOPROTEINS E; COLONY COUNT, MICROBIAL; CROSSES, GENETIC; IMMUNITY, NATURAL; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; LIVER; MICE; MICE, INBRED C57BL; SPLEEN;

EID: 0031687891     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Mahley, R. W. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240: 622-630.
2. Terkeltaub, R. A., C. A. Dyer, J. Martin, and L. K. Curtiss. 1991. Apolipoprotein (apo)-E inhibits the capacity of monosodium urate crystals to stimulate neutrophils - characterization of intraarticular apoE and demonstration of apoE binding to urate crystals in vivo. J. Clin. Invest. 87: 20-26.
3. Curtiss, L. K., and T. S. Edgington. 1981. The biologic activity of the immunoregulatory lipoprotein, LDL-In is independent of its free fatty acid content. J. Immunol. 126: 1382-1386.
4. Pepe, M. G., and L. K. Curtiss. 1986. Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein LDL-In. J. Immunol. 136: 3716-3723.
5. Kelly, M. E., M. A. Clay, M. J. Mistry, H-M. Hsieh-Li, and J. A. K. Harmony. 1994. Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity. Cell. Immunol. 159: 124-139.
6. Mistry, M. J., M. A. Clay, M. E. Kelly, M. A. Steiner, and J. A. K. Harmony. 1995. Apolipoprotein E restricts interleukin-dependent T lymphocyte proliferation at the G1(A)/G1(B) boundary. Cell. Immunol. 160: 14-23.
7. Dyer, C. A., R. S. Smith, and L. K. Curtiss. 1991. Only multimers of a synthetic peptide of human apolipoprotein E are biologically active. J. Biol. Chem. 266: 15009-15015.
8. Clay, M. A., G. M. Anantharamaiah, M. J. Mistry, A. Balasubramaniam, and J. A. K. Harmony. 1995. Localization of a domain in apolipoprotein E with both cytostatic and cytotoxic activity. Biochemistry. 34: 11142-11151.
9. Unanue, E. R. 1997. Inter-relationship among macrophages, natural killer cells and neutrophils in early stages of Listeria resistance. Curr. Opin. Immunol. 9: 35-43.
10. Milon, G. 1997. Listeria monocytogenes in laboratory mice: a model of short-term infectious and pathogenic processes controllable by regulated protective immune responses. Immunol. Rev. 158: 37-46.
11. Piedrahita, J. A., S. H. Zhang, J. R. Hagaman, P. M. Oliver, and N. Maeda. 1992. Generation of mice carrying a mutant apolipoprotein-E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. USA. 89: 4471-4475.
12. Plump, A. S., J. D. Smith, T. Hayek, K. Aalto-Setala, A. Walsh, J. G. Verstuyft, E. M. Rubin, and J. L. Breslow. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71: 343-353.
13. Buchmeier, N., and R. D. Schreiber. 1985. Requirement of endogenous interferon-γ production for resolution of Listeria monocytogenes infection. Proc. Natl. Acad. Sci. USA. 82: 7404-7408.
14. Tripp, C. S., S. F. Wolf, and E. R. Unanue. 1993. Interleukin 12 and tumor necrosis factor α are costimulators of interferon-γ production by natural killer cells in severe combined immunodeficiency mice with listerosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA. 90: 3725-3729.
15. Beutler, B., V. Tkacenko, I. Milsark, N. Krochin, and A. Cerami. 1986. Effect of Interferon-γ on cachectin expression by mononuclear phagocytes. J. Exp. Med. 164: 1791-1796.
16. Zhang, S. H., R. L. Reddick, J. A. Piedrahita, and N. Maeda. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258: 468-471.
17. Ishibashi, S., M. S. Brown, J. L. Goldstein, R. D. Gerard, R. E. Hammer, and J. Herz. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92: 883-893.
18. Dansky, H. M., S. A. Charlton, M. M. Harper, and J. D. Smith. 1997. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Prof. Natl. Acad. Sci. USA. 94: 4642-4646.
19. Daugherty, A., E. Pure, D. Delfel-Butteiger, S. Chen, J. Leferovich, S. E. Roselaar, and D. J. Rader. 1997. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/-mice. J. Clin. Invest. 100: 1575-1580.
20. Gupta, S., A. M. Pablo, X. C. Jiang, N. Wang, A. R. Tall, and C. Schindler. 1997. IFN-gamma potentiates atherosclerosis in apoE knockout mice. J. Clin. Invest. 99: 2752-2761.